Rafferty Asset Management, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,796,445
+16.8%
215,971
+5.7%
0.06%
+23.4%
Q2 2023$8,386,040
+15.1%
204,388
+0.2%
0.05%
-4.1%
Q1 2023$7,286,921
-11.9%
203,887
-6.9%
0.05%
-29.0%
Q4 2022$8,270,837
+23.0%
218,979
+44.1%
0.07%
-4.2%
Q3 2022$6,722,000
+52.2%
151,974
+27.4%
0.07%
+75.6%
Q2 2022$4,416,000
-33.3%
119,283
-33.3%
0.04%
+5.1%
Q1 2022$6,623,000
+14.8%
178,794
-5.7%
0.04%
+30.0%
Q4 2021$5,771,000
+77.8%
189,639
+96.0%
0.03%
+36.4%
Q3 2021$3,245,000
+18.3%
96,737
+40.7%
0.02%
+29.4%
Q2 2021$2,743,000
-3.0%
68,772
+9.4%
0.02%
-10.5%
Q1 2021$2,827,000
+145.8%
62,884
+209.0%
0.02%
+72.7%
Q4 2020$1,150,000
-36.5%
20,348
-46.7%
0.01%
-50.0%
Q3 2020$1,812,000
+86.4%
38,179
+131.6%
0.02%
+57.1%
Q2 2020$972,000
+174.6%
16,484
+120.0%
0.01%
-6.7%
Q1 2020$354,000
-90.6%
7,494
-88.0%
0.02%
-74.1%
Q4 2019$3,772,000
-35.9%
62,437
-36.4%
0.06%
-37.0%
Q3 2019$5,881,000
+14.6%
98,163
+22.9%
0.09%
+2.2%
Q2 2019$5,133,000
-10.2%
79,864
+13.5%
0.09%
-2.2%
Q1 2019$5,713,00070,3870.09%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders